Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Cancer Genomics & Proteomics
|
January 3, 2012
KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma
Thomas Wiedl, Stéphane Collaud, Sven Hillinger, et al.
Cancer
|
March 31, 2011
Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma
Gerhard F Huber, Andrea Albinger-Hegyi, Alex Soltermann, et al.
Head & Neck
|
June 4, 2014
Histopathological mapping of metastatic tumor cells in sentinel lymph nodes of oral and oropharyngeal squamous cell carcinomas
Seraina Denoth, Martina A Broglie, Stephan K Haerle, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2011
Proteomic surfaceome analysis of mesothelioma
Annemarie Ziegler, Ferdinando Cerciello, Colette Bigosch, et al.
Plos One
|
October 1, 2015
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis
Svenja Thies, Martina Friess, Lukas Frischknecht, et al.
Head & Neck
|
March 20, 2013
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
Martina A Broglie, Alex Soltermann, David Rohrbach, et al.
The American Journal of Surgical Pathology
|
February 28, 2008
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases
Anja M Schmitt, Florian Riniker, Martin Anlauf, et al.
BMC Cancer
|
June 7, 2011
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Gerhard F Huber, Lena Züllig, Alex Soltermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
Irene A Burger, Ruben Casanova, Seraina Steiger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 12, 2009
A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
Brian Z Ring, Robert S Seitz, Rodney A Beck, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Cancer Genomics & Proteomics
|
January 3, 2012
KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma
Thomas Wiedl, Stéphane Collaud, Sven Hillinger, et al.
Cancer
|
March 31, 2011
Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma
Gerhard F Huber, Andrea Albinger-Hegyi, Alex Soltermann, et al.
Head & Neck
|
June 4, 2014
Histopathological mapping of metastatic tumor cells in sentinel lymph nodes of oral and oropharyngeal squamous cell carcinomas
Seraina Denoth, Martina A Broglie, Stephan K Haerle, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2011
Proteomic surfaceome analysis of mesothelioma
Annemarie Ziegler, Ferdinando Cerciello, Colette Bigosch, et al.
Plos One
|
October 1, 2015
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis
Svenja Thies, Martina Friess, Lukas Frischknecht, et al.
Head & Neck
|
March 20, 2013
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
Martina A Broglie, Alex Soltermann, David Rohrbach, et al.
The American Journal of Surgical Pathology
|
February 28, 2008
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases
Anja M Schmitt, Florian Riniker, Martin Anlauf, et al.
BMC Cancer
|
June 7, 2011
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Gerhard F Huber, Lena Züllig, Alex Soltermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
Irene A Burger, Ruben Casanova, Seraina Steiger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 12, 2009
A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
Brian Z Ring, Robert S Seitz, Rodney A Beck, et al.
Page
of 12